The AUCs for PSAD and PSAD + MLR for predicting PCa in patients with a PSA level of 4.0–10 or 10–22 ng/mL were 0.7969, 0.8484, 0.8273, and 0.8968, respectively (Table 5, Figure 4). This evidence concerns the gene KLK3 and posterior cortical atrophy.